Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05452642 · ClinicalTrials.gov registry record · NA
The Supporting Understanding of PCOS Education and Research (SUPER) Study
A NA study of Polycystic Ovary, sponsored by University of Michigan.
- Active
- Registry status
- NA
- Development phase
- 223
- Enrollment target
- 1
- Study location
NCT05452642 is a NA study of Polycystic Ovary that is active but no longer recruiting, run by University of Michigan. The registered enrollment target is 223 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05452642, a NA study of Polycystic Ovary, is active but no longer recruiting, sponsored by University of Michigan.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 223 participants
- Enrollment target
- 1
- Study location
Study Summary
This research will test whether a Dietary Approaches to Stop Hypertension (DASH) or a very low-carbohydrate diet better improves outcomes like blood glucose control and body weight for adults with polycystic ovary syndrome. Participants will have screening (includes blood draw) and baseline testing with a continuous glucose monitor and a body composition scan (called a dual-energy x-ray absorptiometry or DEXA). Once these enrollment steps are completed and the participants will be randomized to one of two 12-month programs.
Conditions Studied
Interventions
- BEHAVIORAL DASH diet
- BEHAVIORAL Very low-carbohydrate diet
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 223 participants |
| Start Date | 2022-08-15 |
| Est. Completion | 2026-07-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05452642
The ClinicalTrials.gov registry entry for NCT05452642 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 223 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Polycystic Ovary appearing as the primary indexed condition, and to 2 interventions - of which DASH diet is the first listed.
NCT05452642 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT05452642 about?
NCT05452642 is a clinical study titled "The Supporting Understanding of PCOS Education and Research (SUPER) Study". This research will test whether a Dietary Approaches to Stop Hypertension (DASH) or a very low-carbohydrate diet better improves outcomes like blood glucose control and body weight for adults with polycystic ovary syndrome. Participants will have screening (includes blood draw) and baseline testing...
What is the current status of trial NCT05452642?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 223 participants. The study started on 2022-08-15. Estimated completion is 2026-07-15.
What conditions does trial NCT05452642 study?
This clinical trial studies the following conditions: Polycystic Ovary.
What interventions are being tested in trial NCT05452642?
The interventions under investigation include: DASH diet (BEHAVIORAL), Very low-carbohydrate diet (BEHAVIORAL).
Who is sponsoring clinical trial NCT05452642?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05452642 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.